📰 Conveen Active News
Conveen Active News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Conveen Active. Real-time updates on events, politics, business and more.
May 30, 2024
Haemonetics (NYSE:HAE – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Analyst Ratings This is a breakdown of recent ratings […]
May 18, 2024
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Bone Biologics (NASDAQ:BBLG – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings and profitability. Analyst Ratings This is a breakdown of recent […]
May 18, 2024
Bone Biologics (NASDAQ:BBLG – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Profitability This table compares Bone Biologics and Coloplast […]
April 22, 2024
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation. Analyst Recommendations This is a summary of recent […]
February 11, 2024
Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Institutional and Insider Ownership 15.1% of Coloplast A/S […]
December 27, 2023
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Precision Optics (NASDAQ:POCI – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, earnings and valuation. Insider & Institutional Ownership 0.1% of Coloplast A/S […]
September 25, 2023
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Sartorius Stedim Biotech (OTCMKTS:SDMHF – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, analyst recommendations, dividends and profitability. Earnings & Valuation This table compares Coloplast […]
September 25, 2023
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Sartorius Stedim Biotech (OTCMKTS:SDMHF – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk and earnings. Profitability This table compares Coloplast A/S and […]
August 21, 2023
Asahi Intecc (OTC:AHICF – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, profitability, risk and institutional ownership. Insider and Institutional Ownership 25.3% of Asahi Intecc […]
August 21, 2023
Asahi Intecc (OTC:AHICF – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Analyst Recommendations This is a breakdown of current […]